+223.1%
BMNR vs CVS
+54.6%
+168.5%
-90.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.4% | -0.7% | +4.1% | +3.7% |
| 7D | +0.2% | -2.2% | +2.4% | +1.2% |
| 30D | +39.9% | -0.1% | +40.0% | +39.4% |
| 3M | +51.5% | -5.2% | +56.7% | +53.6% |
| 6M | +18.9% | +26.9% | -8.0% | -3.3% |
| YTD | -7.8% | +22.1% | -29.9% | -28.2% |
| 1Y | -47.6% | +30.8% | -78.4% | -64.3% |
| All | +223.1% | +54.6% | +168.5% | +34.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling